Clinical Trial Update: A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar [Phase 2]

View source ↗

Summary

Phase II study evaluating safety and efficacy of short-course amphotericin B emulsion regimens for visceral leishmaniasis (kala-azar) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Amphotericin B Emulsion (amphotericin B emulsion)

Snippet

Sponsor: Banaras Hindu University | Conditions: Visceral Leishmaniasis | Phase 2 | Status: COMPLETED